跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,767 条关于
“Standard & Poor's”
全部
22,767
临床试验
13,795
药物
177
机构
26
资讯
8,769
去年
Ipsen Secures €500 Million Inaugural Rated Public Bond Following Investment Grade Ratings
6个月前
Lonza Completes Strategic Transformation with $3 Billion Divestment of Capsules & Health Ingredients Business
去年
FDA's Drug Review Gold Standard: Implications of Returning to Traditional Approval Processes
2年前
Axi-Cel Demonstrates Survival Benefit in Elderly R/R LBCL Patients
去年
GSK's Meningococcal Group B Vaccine Approved in the Philippines
去年
OncoPrism-HNSCC Biomarker Test Shows Superior Predictive Accuracy for Head and Neck Cancer Immunotherapy
去年
Tegoprazan Outperforms Standard PPI Therapy in Phase 3 GERD Trials
去年
Mirikizumab Shows Efficacy in Crohn's Disease After Standard Therapy Failure
去年
Telomir-1 Outperforms Standard Chemotherapy in Reversing Cancer Gene Silencing
去年
Landmark PKIDS Trial Challenges Standard Pediatric Kidney Stone Treatment Approaches
第 1 页,共 877 页
上一页
下一页